GTHP
vs
S&P 500
GTHP
S&P 500
Over the past 12 months, GTHP has significantly outperformed S&P 500, delivering a return of +256% compared to the S&P 500's +15% growth.
Stocks Performance
GTHP vs S&P 500
Performance Gap
GTHP vs S&P 500
Performance By Year
GTHP vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Guided Therapeutics Inc
Glance View
Guided Therapeutics, Inc. engages in the development of medical devices. The company is headquartered in Norcross, Georgia. The firm is focused on selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. The firm focuses on two primary applications for LuViva as a cancer screening tool, and triage traditional screening. Screening is for cervical cancer represents the practice of diagnostic medicine. The firm is also focused on the extension of its cancer detection technology into other cancers, including esophageal.
